2016 annual financial data
Regencell Bioscience 2016 Operating cash flow growth
Direct answer
Operating cash flow growth was 24.43%.
Operating income was 339,000,000 USD and net income was 153,400,000 USD.
Operating cash flow was 434,400,000 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,127,300,000 USD
- Operating income
- 339,000,000 USD
- Net income
- 153,400,000 USD
- Operating cash flow
- 434,400,000 USD